Metronidazole Injection Shortage: Latest Updates on Availability and Manufacturer Status

What’s in Shortage

Metronidazole Injection, a medication in the anti-infective therapeutic category, is currently listed as being in shortage. This shortage affects the injection dosage form, specifically the 500 mg/100 mL presentation. Brand names associated with this medication include METRONIDAZOLE and Flagyl I.v. Rtu.

Which Manufacturers Are Affected

According to the FDA database, the following manufacturer information is available:

• Baxter Healthcare: Currently listed as “Available.”
  • Presentation: Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48)
  • Contact Information: 888-229-0001

Why There’s a Shortage

The source data does not provide a specific reason for the current shortage of Metronidazole Injection.

What Patients Should Do

If you are a patient who requires Metronidazole Injection, it is important to stay informed about supply levels. We recommend the following steps:

• Consult your healthcare provider: Discuss your treatment plan and ask about the availability of the medication at your treatment facility.
• Speak with a pharmacist: Pharmacists often have the most up-to-date information on local stock and can coordinate with suppliers.
• Contact the manufacturer: You may use the contact information provided above to inquire about supply timelines.

Disclaimer: Patients should always consult with their healthcare provider or a qualified medical professional regarding their treatment and any potential changes to their medication regimen.

Source

Information for this report is attributed to the FDA Drug Shortage Database.

• Initial Posting Date: 01/13/2022
• Last Updated: 02/02/2026